These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18096249)

  • 1. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
    Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
    Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
    Kim SK; Nguyen Pham TN; Nguyen Hoang TM; Kang HK; Jin CJ; Nam JH; Chung SY; Choi SJ; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
    Ann Hematol; 2009 Nov; 88(11):1113-23. PubMed ID: 19277657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
    Yoon SH; Cho HI; Kim TG
    Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
    J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
    Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated B cells mediate efficient expansion of rare antigen-specific T cells.
    Zentz C; Wiesner M; Man S; Frankenberger B; Wollenberg B; Hillemanns P; Zeidler R; Hammerschmidt W; Moosmann A
    Hum Immunol; 2007 Feb; 68(2):75-85. PubMed ID: 17321896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine model of CD40-activation of B cells.
    Liebig TM; Fiedler A; Klein-Gonzalez N; Shimabukuro-Vornhagen A; von Bergwelt-Baildon M
    J Vis Exp; 2010 Mar; (37):. PubMed ID: 20208476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.
    Van den Bosch GA; Ponsaerts P; Nijs G; Lenjou M; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    Clin Exp Immunol; 2005 Mar; 139(3):458-67. PubMed ID: 15730391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes.
    Ducas E; Dussault N; Roy A; Dumont N; Néron S
    J Immunol Methods; 2009 May; 344(2):133-7. PubMed ID: 19332074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
    Mason NJ; Coughlin CM; Overley B; Cohen JN; Mitchell EL; Colligon TA; Clifford CA; Zurbriggen A; Sorenmo KU; Vonderheide RH
    Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
    Wan Y; Ma X; Li X; Yi J
    Med Hypotheses; 2009 Nov; 73(5):835-7. PubMed ID: 19632790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
    Rodríguez-Pinto D; Moreno J
    Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation.
    Néron S; Nadeau PJ; Darveau A; Leblanc JF
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):25-40. PubMed ID: 21234809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells.
    Shen SN; Xu Z; Qian XP; Ding YT; Yu LX; Liu BR
    Eur J Cancer Care (Engl); 2008 Jul; 17(4):404-11. PubMed ID: 18485013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of long-term culture system for human B cells derived from peripheral blood mononuclear cells activated via soluble CD40 ligand].
    Wu C; Liu Y; Zhao Q; Chen GM; Chen JH; Yan XM; Zhou YH; Huang ZH
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):124-7. PubMed ID: 19489277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new clinically relevant approach to expand myelin specific T cells.
    Arbour N; Lapointe R; Saikali P; McCrea E; Regen T; Antel JP
    J Immunol Methods; 2006 Mar; 310(1-2):53-61. PubMed ID: 16464465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.